Simplex Trading, LLC Dyne Therapeutics, Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$23.65 - $35.63 $996,208 - $1.5 Million	-42,123 Reduced 84.74%	7,583 $267,000
Q1 2024 Apr 25, 2024	BUY	$13.06 - $29.18 $413,283 - $923,401	31,645 Added 175.21%	49,706 $1.41 Million
Q4 2023 Feb 02, 2024	SELL	$6.62 - $13.64 $118,968 - $245,124	-17,971 Reduced 49.88%	18,061 $240,000
Q3 2023 Nov 01, 2023	BUY	$8.6 - $12.18 $309,875 - $438,869	36,032 New	36,032 $322,000
Q2 2022 Aug 03, 2022	BUY	$4.36 - $10.5 $161 - $388	37 New	37 $0

207

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $731M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.